How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
39
SPTN Quote, Financials, Valuation and Earnings
Last price:
$20.73
Seasonality move
:
6.24%
Day range:
$20.30 - $20.84
52-week range:
$17.30 - $23.00
Dividend yield:
4.34%
P/E ratio:
15.77x
P/S ratio:
0.07x
P/B ratio:
0.91x
Volume:
221.5K
Avg. volume:
283K
1-year change:
2.24%
Market cap:
$679M
Revenue:
$9.5B
EPS (TTM):
-$0.01
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.3B | $8.9B | $9.6B | $9.7B | $9.5B | |
| Revenue Growth (YoY) | 9.52% | -4.47% | 7.97% | 0.89% | -1.85% | |
| Cost of Revenues | $7.9B | $7.5B | $8.1B | $8.2B | $8B | |
| Gross Profit | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Gross Profit Margin | 15.24% | 15.72% | 15.53% | 15.27% | 15.84% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.3B | $1.4B | $1.4B | $1.4B | |
| Other Inc / (Exp) | -$23.4M | -$3.3M | $14K | -$9.3M | -$75.3M | |
| Operating Expenses | $1.3B | $1.3B | $1.4B | $1.4B | $1.4B | |
| Operating Income | $127.2M | $115.8M | $69.7M | $119.3M | $131.2M | |
| Net Interest Expenses | $18.4M | $13.9M | $22.8M | $39.9M | $44.8M | |
| EBT. Incl. Unusual Items | $85.4M | $98.7M | $46.9M | $70.1M | $11M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.5M | $24.9M | $12.4M | $17.9M | $10.7M | |
| Net Income to Company | $75.9M | $73.8M | $34.5M | $52.2M | $299K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $75.9M | $73.8M | $34.5M | $52.2M | $299K | |
| Basic EPS (Cont. Ops) | $2.12 | $2.07 | $0.98 | $1.53 | $0.01 | |
| Diluted EPS (Cont. Ops) | $2.12 | $2.05 | $0.95 | $1.50 | $0.01 | |
| Weighted Average Basic Share | $35.9M | $35.6M | $35.3M | $34.2M | $33.8M | |
| Weighted Average Diluted Share | $35.9M | $35.9M | $36.3M | $34.9M | $34.2M | |
| EBITDA | $193.7M | $205.2M | $163.9M | $208.7M | $159.3M | |
| EBIT | $103.8M | $112.5M | $69.7M | $110M | $55.9M | |
| Revenue (Reported) | $9.3B | $8.9B | $9.6B | $9.7B | $9.5B | |
| Operating Income (Reported) | $127.2M | $115.8M | $69.7M | $119.3M | $131.2M | |
| Operating Income (Adjusted) | $103.8M | $112.5M | $69.7M | $110M | $55.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.1B | $2.3B | $2.2B | $2.3B | |
| Revenue Growth (YoY) | 12.47% | -6.84% | 10.3% | -2.77% | 0.73% | |
| Cost of Revenues | $1.9B | $1.8B | $2B | $1.9B | $1.9B | |
| Gross Profit | $338.2M | $322.7M | $341.4M | $339M | $364.5M | |
| Gross Profit Margin | 15.05% | 15.42% | 14.79% | 15.1% | 16.12% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $316.7M | $289.1M | $333.4M | $306.5M | $335.5M | |
| Other Inc / (Exp) | -$3.9M | -$317K | $1.5M | -$8.2M | -$56.7M | |
| Operating Expenses | $316.7M | $289.1M | $333.4M | $306.5M | $335.5M | |
| Operating Income | $21.5M | $33.7M | $8.1M | $32.5M | $29M | |
| Net Interest Expenses | $3.6M | $3M | $8M | $9.7M | $10.9M | |
| EBT. Incl. Unusual Items | $14M | $30.4M | $1.5M | $14.7M | -$38.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9M | $8.1M | $867K | $4.4M | -$3.4M | |
| Net Income to Company | $12.1M | $22.2M | $650K | $10.3M | -$35.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $12.1M | $22.2M | $650K | $10.3M | -$35.1M | |
| Basic EPS (Cont. Ops) | $0.34 | $0.63 | $0.02 | $0.30 | -$1.04 | |
| Diluted EPS (Cont. Ops) | $0.34 | $0.62 | $0.02 | $0.30 | -$1.04 | |
| Weighted Average Basic Share | $38.4M | $37.6M | $34.8M | $34.1M | $33.6M | |
| Weighted Average Diluted Share | $38.4M | $38.2M | $36.1M | $34.7M | $34M | |
| EBITDA | $38.5M | $54.8M | $31.5M | $47.7M | -$2.4M | |
| EBIT | $17.6M | $33.4M | $9.5M | $24.3M | -$27.6M | |
| Revenue (Reported) | $2.2B | $2.1B | $2.3B | $2.2B | $2.3B | |
| Operating Income (Reported) | $21.5M | $33.7M | $8.1M | $32.5M | $29M | |
| Operating Income (Adjusted) | $17.6M | $33.4M | $9.5M | $24.3M | -$27.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.3B | $8.9B | $9.6B | $9.7B | $9.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7.9B | $7.5B | $8.1B | $8.2B | $8B | |
| Gross Profit | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.3B | $1.4B | $1.4B | $1.4B | |
| Other Inc / (Exp) | -$23.4M | -$3.3M | $14K | -$9.3M | -$75.3M | |
| Operating Expenses | $1.3B | $1.3B | $1.4B | $1.4B | $1.4B | |
| Operating Income | $127.2M | $115.8M | $69.7M | $119.3M | $131.2M | |
| Net Interest Expenses | $18.4M | $13.9M | $22.8M | $39.9M | $44.8M | |
| EBT. Incl. Unusual Items | $85.4M | $98.7M | $46.9M | $70.1M | $11M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.5M | $24.9M | $12.4M | $17.9M | $10.7M | |
| Net Income to Company | $75.9M | $73.8M | $34.5M | $52.2M | $299K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $75.9M | $73.8M | $34.5M | $52.2M | $299K | |
| Basic EPS (Cont. Ops) | $2.13 | $2.08 | $0.97 | $1.53 | $0.01 | |
| Diluted EPS (Cont. Ops) | $2.13 | $2.05 | $0.95 | $1.50 | -$0.01 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $193.7M | $205.2M | $163.9M | $208.7M | $159.3M | |
| EBIT | $103.8M | $112.5M | $69.7M | $110M | $55.9M | |
| Revenue (Reported) | $9.3B | $8.9B | $9.6B | $9.7B | $9.5B | |
| Operating Income (Reported) | $127.2M | $115.8M | $69.7M | $119.3M | $131.2M | |
| Operating Income (Adjusted) | $103.8M | $112.5M | $69.7M | $110M | $55.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.9B | $9.6B | $9.7B | $9.5B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7.5B | $8.1B | $8.2B | $8B | -- | |
| Gross Profit | $1.4B | $1.5B | $1.5B | $1.5B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.4B | $1.4B | $1.4B | -- | |
| Other Inc / (Exp) | -$3.3M | $14K | -$9.3M | -$75.3M | -- | |
| Operating Expenses | $1.3B | $1.4B | $1.4B | $1.4B | -- | |
| Operating Income | $115.8M | $69.7M | $119.3M | $131.2M | -- | |
| Net Interest Expenses | $13.9M | $22.8M | $39.9M | $44.8M | -- | |
| EBT. Incl. Unusual Items | $98.7M | $46.9M | $70.1M | $11M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $24.9M | $12.4M | $17.9M | $10.7M | -- | |
| Net Income to Company | $73.8M | $34.5M | $52.2M | $299K | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $73.8M | $34.5M | $52.2M | $299K | -- | |
| Basic EPS (Cont. Ops) | $2.08 | $0.97 | $1.53 | $0.01 | -- | |
| Diluted EPS (Cont. Ops) | $2.05 | $0.95 | $1.50 | -$0.01 | -- | |
| Weighted Average Basic Share | $142.6M | $141M | $136.2M | $134.7M | -- | |
| Weighted Average Diluted Share | $143.8M | $143.8M | $138.8M | $136.3M | -- | |
| EBITDA | $205.2M | $163.9M | $208.7M | $159.3M | -- | |
| EBIT | $112.5M | $69.7M | $110M | $55.9M | -- | |
| Revenue (Reported) | $8.9B | $9.6B | $9.7B | $9.5B | -- | |
| Operating Income (Reported) | $115.8M | $69.7M | $119.3M | $131.2M | -- | |
| Operating Income (Adjusted) | $112.5M | $69.7M | $110M | $55.9M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $19.9M | $10.7M | $29.1M | $18M | $21.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $337.3M | $328.1M | $375.6M | $379.2M | $386.8M | |
| Inventory | $541.8M | $522.3M | $571.1M | $575.2M | $546.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $72.2M | $62.5M | $62.2M | $62.4M | $75M | |
| Total Current Assets | $1B | $957.2M | $1.1B | $1.1B | $1.1B | |
| Property Plant And Equipment | $866.2M | $860.4M | $867.3M | $891.2M | $1.1B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $181M | $181M | $182.2M | $182.2M | $181M | |
| Other Intangibles | $116.1M | $111M | $106.3M | $101.5M | $117.8M | |
| Other Long-Term Assets | $99.2M | $97.2M | $84.4M | $103.2M | $104.4M | |
| Total Assets | $2.3B | $2.2B | $2.3B | $2.4B | $2.6B | |
| Accounts Payable | $464.8M | $447.5M | $487.2M | $473.4M | $485M | |
| Accrued Expenses | $173.8M | $154.2M | $165.5M | $135.7M | $147.8M | |
| Current Portion Of Long-Term Debt | $5.1M | $6.3M | $6.8M | $8.8M | $12.8M | |
| Current Portion Of Capital Lease Obligations | $45.8M | $47.8M | $45.5M | $42M | $49.6M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $689.6M | $655.8M | $705M | $659.9M | $695.2M | |
| Long-Term Debt | $481.3M | $399.4M | $496.8M | $588.7M | $741M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.5B | $1.4B | $1.5B | $1.6B | $1.9B | |
| Common Stock | $491.8M | $493.8M | $468.1M | $460.3M | $454.8M | |
| Other Common Equity Adj | -$2.3M | -$1.5M | $3M | $796K | $1.3M | |
| Common Equity | $735M | $782.9M | $766.1M | $778.2M | $743.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $735M | $782.9M | $766.1M | $778.2M | $743.5M | |
| Total Liabilities and Equity | $2.3B | $2.2B | $2.3B | $2.4B | $2.6B | |
| Cash and Short Terms | $19.9M | $10.7M | $29.1M | $18M | $21.6M | |
| Total Debt | $486.4M | $405.7M | $503.6M | $597.5M | $753.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $19.9M | $10.7M | $29.1M | $18M | $21.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $337.3M | $328.1M | $375.6M | $379.2M | $386.8M | |
| Inventory | $541.8M | $522.3M | $571.1M | $575.2M | $546.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $72.2M | $62.5M | $62.2M | $62.4M | $75M | |
| Total Current Assets | $1B | $957.2M | $1.1B | $1.1B | $1.1B | |
| Property Plant And Equipment | $866.2M | $860.4M | $867.3M | $891.2M | $1.1B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $181M | $181M | $182.2M | $182.2M | $181M | |
| Other Intangibles | $116.1M | $111M | $106.3M | $101.5M | $117.8M | |
| Other Long-Term Assets | $99.2M | $97.2M | $84.4M | $103.2M | $104.4M | |
| Total Assets | $2.3B | $2.2B | $2.3B | $2.4B | $2.6B | |
| Accounts Payable | $464.8M | $447.5M | $487.2M | $473.4M | $485M | |
| Accrued Expenses | $173.8M | $154.2M | $165.5M | $135.7M | $147.8M | |
| Current Portion Of Long-Term Debt | $5.1M | $6.3M | $6.8M | $8.8M | $12.8M | |
| Current Portion Of Capital Lease Obligations | $45.8M | $47.8M | $45.5M | $42M | $49.6M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $689.6M | $655.8M | $705M | $659.9M | $695.2M | |
| Long-Term Debt | $481.3M | $399.4M | $496.8M | $588.7M | $741M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.5B | $1.4B | $1.5B | $1.6B | $1.9B | |
| Common Stock | $491.8M | $493.8M | $468.1M | $460.3M | $454.8M | |
| Other Common Equity Adj | -$2.3M | -$1.5M | $3M | $796K | $1.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $735M | $782.9M | $766.1M | $778.2M | $743.5M | |
| Total Liabilities and Equity | $2.3B | $2.2B | $2.3B | $2.4B | $2.6B | |
| Cash and Short Terms | $19.9M | $10.7M | $29.1M | $18M | $21.6M | |
| Total Debt | $486.4M | $405.7M | $503.6M | $597.5M | $753.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $75.9M | $73.8M | $34.5M | $52.2M | $299K | |
| Depreciation & Amoritzation | $89.9M | $92.7M | $94.2M | $98.6M | $103.4M | |
| Stock-Based Compensation | $6.3M | $6.9M | $8.4M | $12.3M | $10.7M | |
| Change in Accounts Receivable | -$12.9M | -$4M | -$38.2M | -$17.2M | -$25.6M | |
| Change in Inventories | -$7M | $320K | -$92.3M | -$21.9M | $59.8M | |
| Cash From Operations | $306.7M | $161.2M | $110.4M | $89.3M | $205.9M | |
| Capital Expenditures | $67.3M | $79.4M | $97.3M | $120.3M | $132.4M | |
| Cash Acquisitions | -- | -- | -$41.4M | -$780K | -$117.9M | |
| Cash From Investing | -$57.2M | -$48M | -$100.9M | -$116.5M | -$247M | |
| Dividends Paid (Ex Special Dividend) | -$34.5M | -$28.3M | -$29.7M | -$29.7M | -$29.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.4B | $1.4B | $1.5B | $1.4B | $1.4B | |
| Long-Term Debt Repaid | -$1.6B | -$1.5B | -$1.4B | -$1.3B | -$1.3B | |
| Repurchase of Common Stock | -$10M | -$5.3M | -$32.5M | -$18.5M | -$15M | |
| Other Financing Activities | -$453K | -$262K | -$3.8M | -$1.2M | -$1.4M | |
| Cash From Financing | -$253.8M | -$122.4M | $9M | $16.1M | $44.8M | |
| Beginning Cash (CF) | $24.2M | $19.9M | $10.7M | $29.1M | $18M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$4.3M | -$9.2M | $18.4M | -$11.1M | $3.6M | |
| Ending Cash (CF) | $19.9M | $10.7M | $29.1M | $18M | $21.6M | |
| Levered Free Cash Flow | $239.4M | $81.7M | $13.1M | -$31M | $73.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $12.1M | $22.2M | $650K | $10.3M | -$35.1M | |
| Depreciation & Amoritzation | $20.9M | $21.5M | $21.9M | $23.4M | $25.3M | |
| Stock-Based Compensation | $1M | $891K | $1.4M | $2.3M | $2.6M | |
| Change in Accounts Receivable | $29.9M | $10.3M | $30M | $5.8M | $40.5M | |
| Change in Inventories | $45.5M | $19.6M | $48.4M | $10.8M | $43.2M | |
| Cash From Operations | $82.9M | $17.2M | $102.9M | -$6.4M | $82.6M | |
| Capital Expenditures | $21.4M | $24.5M | $31M | $34.1M | $34.5M | |
| Cash Acquisitions | -- | -- | -$32M | -- | -$103.6M | |
| Cash From Investing | -$21.7M | -$23.9M | -$55M | -$34.5M | -$136.4M | |
| Dividends Paid (Ex Special Dividend) | -$6.9M | -$7M | -$7.3M | -$7.3M | -$7.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $393.7M | $327.4M | $411M | $316.3M | $375.3M | |
| Long-Term Debt Repaid | -$454.6M | -$327.7M | -$428.7M | -$267.3M | -$309.6M | |
| Repurchase of Common Stock | -- | -- | -$9.2M | -- | $51K | |
| Other Financing Activities | -$246K | -$6K | -$3.7M | -$416K | -$636K | |
| Cash From Financing | -$68.2M | -$7.3M | -$37.8M | $41.3M | $57.8M | |
| Beginning Cash (CF) | $26.9M | $24.6M | $19M | $17.6M | $17.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$7M | -$14M | $10.1M | $410K | $4.1M | |
| Ending Cash (CF) | $19.9M | $10.7M | $29.1M | $18M | $21.6M | |
| Levered Free Cash Flow | $61.5M | -$7.3M | $71.9M | -$40.5M | $48.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $75.9M | $73.8M | $34.5M | $52.2M | $299K | |
| Depreciation & Amoritzation | $89.9M | $92.7M | $94.2M | $98.6M | $103.4M | |
| Stock-Based Compensation | $6.3M | $6.9M | $8.4M | $12.3M | $10.7M | |
| Change in Accounts Receivable | -$12.9M | -$4M | -$38.2M | -$17.2M | -$25.6M | |
| Change in Inventories | -$7M | $320K | -$92.3M | -$21.9M | $59.8M | |
| Cash From Operations | $306.7M | $161.2M | $110.4M | $89.3M | $205.9M | |
| Capital Expenditures | $67.3M | $79.4M | $97.3M | $120.3M | $132.4M | |
| Cash Acquisitions | -- | -- | -$41.4M | -$780K | -$117.9M | |
| Cash From Investing | -$57.2M | -$48M | -$100.9M | -$116.5M | -$247M | |
| Dividends Paid (Ex Special Dividend) | -$34.5M | -$28.3M | -$29.7M | -$29.7M | -$29.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.4B | $1.4B | $1.5B | $1.4B | $1.4B | |
| Long-Term Debt Repaid | -$1.6B | -$1.5B | -$1.4B | -$1.3B | -$1.3B | |
| Repurchase of Common Stock | -$10M | -- | -$32.5M | -$18.5M | -$15M | |
| Other Financing Activities | -$453K | -$262K | -$3.8M | -$1.2M | -$1.4M | |
| Cash From Financing | -$253.8M | -$122.4M | $9M | $16.1M | $44.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$4.3M | -$9.2M | $18.4M | -$11.1M | $3.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $239.4M | $81.7M | $13.1M | -$31M | $73.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $73.8M | $34.5M | $52.2M | $299K | -- | |
| Depreciation & Amoritzation | $92.7M | $94.2M | $98.6M | $103.4M | -- | |
| Stock-Based Compensation | $6.9M | $8.4M | $12.3M | $10.7M | -- | |
| Change in Accounts Receivable | -$4M | -$38.2M | -$17.2M | -$25.6M | -- | |
| Change in Inventories | $320K | -$92.3M | -$21.9M | $59.8M | -- | |
| Cash From Operations | $161.2M | $110.4M | $89.3M | $205.9M | -- | |
| Capital Expenditures | $79.4M | $97.3M | $120.3M | $132.4M | -- | |
| Cash Acquisitions | -- | -$41.4M | -$780K | -$117.9M | -- | |
| Cash From Investing | -$48M | -$100.9M | -$116.5M | -$247M | -- | |
| Dividends Paid (Ex Special Dividend) | -$28.3M | -$29.7M | -$29.7M | -$29.9M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.4B | $1.5B | $1.4B | $1.4B | -- | |
| Long-Term Debt Repaid | -$1.5B | -$1.4B | -$1.3B | -$1.3B | -- | |
| Repurchase of Common Stock | -$5.3M | -$32.5M | -$18.5M | -$15M | -- | |
| Other Financing Activities | -$262K | -$3.8M | -$1.2M | -$1.4M | -- | |
| Cash From Financing | -$122.4M | $9M | $16.1M | $44.8M | -- | |
| Beginning Cash (CF) | $92M | $67.2M | $80.5M | $79.7M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$9.2M | $18.4M | -$11.1M | $3.6M | -- | |
| Ending Cash (CF) | $82.7M | $85.6M | $69.4M | $83.3M | -- | |
| Levered Free Cash Flow | $81.7M | $13.1M | -$31M | $73.5M | -- | |
Get SPTN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SPTN
Sector
P/E ratio
15.77x
18.23x
PEG ratio
1.75x
0.28x
P/B ratio
0.91x
1.58x
Price / LTM sales
0.07x
0.60x
Growth Metrics
SPTN
Sector
Revenue growth
0.73%
2.13%
Earnings growth
--
4.62%
Revenue (5-year growth)
2.27%
4.1%
Earnings forecast
$0.43
$0.31
Profitability
SPTN
Sector
Profitability FY 2024
$1.5B
$541.6M
Return on invested capital
0.02%
5.48%
Return on assets
0.01%
3.56%
Return on equity
0.04%
8.28%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
May
30
Estimated Next Earnings Date
May
14
Balance Sheet
SPTN
Sector
Total cash
$21.6M
$149.2M
Short term investments
--
$41.9M
Total assets
$2.6B
$1.8B
Long term debt
$753.8M
$220M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
61
AGX alert for Apr 23
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
